Clinical Trial Update: Daratumumab in Combination With ATRA [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating daratumumab in combination with ATRA in multiple myeloma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• ATRA (all-trans retinoic acid)
• Daratumumab (daratumumab)

Snippet

Sponsor: Amsterdam UMC, location VUmc | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: COMPLETED